2 research outputs found
WO<sub>3</sub>/Conducting Polymer Heterojunction Photoanodes for Efficient and Stable Photoelectrochemical Water Splitting
An
efficient and stable heterojunction photoanode for solar water oxidation
was fabricated by hybridization of WO<sub>3</sub> and conducting polymers
(CPs). Organic/inorganic hybrid photoanodes were readily prepared
by the electropolymerization of various CPs and the codeposition of
tetraruthenium polyoxometalate (Ru<sub>4</sub>POM) water-oxidation
catalysts (WOCs) on the surface of WO<sub>3</sub>. The deposition
of CPs, especially polypyrrole (PPy) doped with Ru<sub>4</sub>POM
(PPy:Ru<sub>4</sub>POM), resulted in a remarkably improved photoelectrochemical
performance by the formation of a WO<sub>3</sub>/PPy p–n heterojunction
and the incorporation of efficient Ru<sub>4</sub>POM WOCs. In addition,
there was also a significant improvement in the photostability of
the WO<sub>3</sub>-based photoanode after the deposition of the PPy:Ru<sub>4</sub>POM layer due to the suppression of the formation of hydrogen
peroxide, which was responsible for corrosion. This study provides
insight into the design and fabrication of novel photosynthetic and
photocatalytic systems with excellent performance and stability through
the hybridization of organic and inorganic materials
Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin
Isorhamnetin (<b>1</b>) is
a naturally occurring flavonoid having anticancer and anti-inflammatory
properties. The present study demonstrated that <b>1</b> had
antimycobacterial effects on <i>Mycobacterium tuberculosis</i> H<sub>37</sub>Rv, multi-drug- and extensively drug-resistant clinical
isolates with minimum inhibitory concentrations of 158 and 316 μM,
respectively. Mycobacteria mainly affect the lungs, causing an intense
local inflammatory response that is critical to the pathogenesis of
tuberculosis. We investigated the effects of <b>1</b> on interferon
(IFN)-γ-stimulated human lung fibroblast MRC-5 cells. Isorhamnetin
suppressed the release of tumor necrosis factor (TNF)-α and
interleukin (IL)-12. A nontoxic dose of <b>1</b> reduced mRNA
expression of TNF-α, IL-1β, IL-6, IL-12, and matrix metalloproteinase-1
in IFN-γ-stimulated cells. Isorhamnetin inhibited IFN-γ-mediated
stimulation of extracellular signal-regulated kinase and p38 mitogen-activated
protein kinase and showed high-affinity binding to these kinases (binding
constants: 4.46 × 10<sup>6</sup> M<sup>–1</sup> and 7.6
× 10<sup>6</sup> M<sup>–1</sup>, respectively). The 4′-hydroxy
group and the 3′-methoxy group of the B-ring and the 5-hydroxy
group of the A-ring of <b>1</b> play key roles in these binding
interactions. A mouse <i>in vivo</i> study of lipopolysaccharide-induced
lung inflammation revealed that a nontoxic dose of <b>1</b> reduced
the levels of IL-1β, IL-6, IL-12, and INF-γ in lung tissue.
These data provide the first evidence that <b>1</b> could be
developed as a potent antituberculosis drug